Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 33.35
-0.329 %
$ 1.08 B
Market Cap
14.25
P/E
Price Target
Average
28.44%
Revenue Forecast
Estimate
4.99%
EBIT
Estimate
--25.46%
Net Income
Estimate
112.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Collegium Pharmaceutical, Inc.
Wall Street analysts predict an average 1-year price target for COLL of $42.8 , with forecasts ranging from
a
low of
$37 to a high of $50 .
COLL Lowest Price Target
Wall Street Target
37 USD
10.94%
COLL Average Price Target
Wall Street Target
42.8 USD
28.44%
COLL Highest Price Target
Wall Street Target
50 USD
49.93%
REVENUE FORECAST
Revenue Forecast Chart COLL
EBIT FORECAST
EBIT Forecast Chart COLL
NET INCOME FORECAST
Net Income Chart COLL